In a recent study, ERK inhibition induced autophagy in KRAS-mutant PDAC and the dual ERK and autophagy inhibition, using SCH772984 and hydrochloroquine, respectively, resulted in enhanced anti-tumor activity in PDAC preclinical models [43,49]. The gene discussed is KRAS; the disease is neoplasm.